School of Medicine - Medicine

  • Professor Cardiology
  • SONG, YOUNG BIN
CV1

Research Interest

1) Coronary artery disease
2) Percutaneous coronary intervention
3) Invasive imaging and Physiology
4) Noninvasive Cardiovascular Imaging (MRI)
5) Atherosclerosis
6) Myocardial infarction

Education

  • 2009 Ph. Doctor, College of Medicine, Chung-Ang University
  • 2002 Bachelor, College of Medicine, Chung-Ang University
  • 1998 Master, College of Medicine, Chung-Ang University

Experience

  • 1998 - 1999 Internship, Chung-Ang University Hospital
  • 1999 - 2003 Residency, Internal Medicine, Chung-Ang University Hospital
  • 2003 - 2006 Military doctor for a military service
  • 2006 - 2008 Fellowship, Department of Cardiology, Samsung Medical Center
  • 2008 - 2011 Clinical Assistant Professor, Department of Cardiology, Samsung Medical Center
  • 2011 - 2015 Assistant Professor, Department of Cardiology, Samsung Medical Center
  • 2015 - 2016 Visiting Scholarship, Johns Hopkins Hospital
  • 2015 - 2021 Associate Professor, Heart Vascular Stroke Institute, Department of Cardiology, Samsung Medical Center
  • 2021 - Professor, Heart Vascular Stroke Institute, Department of Cardiology, Samsung Medical Center

Journal Articles

  • (2024)  Differential Impact of Fractional Flow Reserve Measured After Coronary Stent Implantation by Left Ventricular Dysfunction.  JACC: Asia.  4,  3
  • (2024)  Prognostic Implication of Platelet Reactivity According to Procedural Complexity After PCI: Subanalysis of PTRG-DES Consortium.  JACC: Asia.  4,  3
  • (2024)  Intravascular Imaging-Guided Percutaneous Coronary Intervention Before and After Standardized Optimization Protocols.  JACC-CARDIOVASCULAR INTERVENTIONS.  17,  2
  • (2024)  Prognostic Implication of Platelet Reactivity According to Left Ventricular Systolic Dysfunction Status in Patients Treated With Drug-Eluting Stent Implantation: Analysis of the PTRG-DES Consortium.  JOURNAL OF KOREAN MEDICAL SCIENCE.  39,  3
  • (2024)  High platelet reactivity strongly predicts early stent thrombosis in patients with drug-eluting stent implantation.  SCIENTIFIC REPORTS.  14,  1
  • (2024)  Angiographic Severity of the Nonculprit Lesion and the Efficacy of Fractional Flow Reserve-Guided Complete Revascularization in Patients With AMI: FRAME-AMI Substudy.  CIRCULATION-CARDIOVASCULAR INTERVENTIONS.  17,  1
  • (2024)  Cost-Effectiveness of Fractional Flow Reserve-Guided Treatment for Acute Myocardial Infarction and Multivessel Disease: A Prespecified Analysis of the FRAME-AMI Randomized Clinical Trial.  JAMA NETWORK OPEN.  7,  1
  • (2023)  Clinical Benefit of Intravascular Imaging Compared with Conventional Angiography in Left Main Coronary Artery Intervention.  CIRCULATION-CARDIOVASCULAR INTERVENTIONS.  16,  12
  • (2023)  Clinical Outcomes of Deferred Lesions by IVUS Versus FFR-Guided Treatment Decision.  CIRCULATION-CARDIOVASCULAR INTERVENTIONS.  16,  12
  • (2023)  Sex-Based Outcomes of P2Y12 Inhibitor Monotherapy After Three Months of Dual Antiplatelet Therapy in Patients Undergoing Percutaneous Coronary Intervention.  JOURNAL OF KOREAN MEDICAL SCIENCE.  38,  45
  • (2023)  High Platelet Reactivity Combined with CYP2C19 Genotype in Predicting Outcomes in East Asian Patients Undergoing Percutaneous Coronary Intervention.  CLINICAL PHARMACOLOGY & THERAPEUTICS.  114,  5
  • (2023)  Intravascular Imaging in Patients With Complex Coronary Lesions and Chronic Kidney Disease.  JAMA NETWORK OPEN.  6,  11
  • (2023)  QFR Assessment and Prognosis After Nonculprit PCI in Patients With Acute Myocardial Infarction.  JACC-CARDIOVASCULAR INTERVENTIONS.  16,  19
  • (2023)  Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.  CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.  102,  4
  • (2023)  Comparison of Outcomes Between 1- and 2-Stent Techniques for Medina Classification 0.0.1 Coronary Bifurcation Lesions.  JACC-CARDIOVASCULAR INTERVENTIONS.  16,  17
  • (2023)  Implication of diabetic status on platelet reactivity and clinical outcomes after drug-eluting stent implantation: results from the PTRG-DES consortium.  CARDIOVASCULAR DIABETOLOGY.  22,  1
  • (2023)  An unusual no-reflow phenomenon due to neointimal tissue embolization during drug eluting balloon intervention in stent restenosis: A case report.  CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS.  102,  3
  • (2023)  Efficacy of thrombus aspiration in cardiogenic shock complicating acute myocardial infarction and high thrombus burden.  REVISTA ESPANOLA DE CARDIOLOGIA.  76,  9
  • (2023)  Prognostic Impact of Operator Experience and IVUS Guidance on Long-Term Clinical Outcomes After Complex PCI.  JACC-CARDIOVASCULAR INTERVENTIONS.  16,  14
  • (2023)  Comparison Between Fimasartan Versus Other Angiotensin Receptor Blockers in Patients With Heart Failure After Acute Myocardial Infarction.  JOURNAL OF KOREAN MEDICAL SCIENCE.  38,  25

Conference Paper

  • (2023)  Optimizing PCI in LM & LM Bifurcation Lesions?.  대한심장학회 제67차 추계학술대회.  KOREA, REPUBLIC OF
  • (2023)  How to Optimize the Stented Segment, Review of Recent Expert Consensus for the Use of Intravascular Imaging.  대한심혈관중재학회 제42차 하계국제학술대회.  KOREA, REPUBLIC OF
  • (2022)  Choice of SAPT after stabilization of patients undergoing PCI.  ENCORE SEOUL 2022.  KOREA, REPUBLIC OF
  • (2022)  Trends of bifurcation PCI: Lessons from COBIS series.  ENCORE SEOUL 2022.  KOREA, REPUBLIC OF
  • (2022)  Case-based sessions with Video Demo Complex PCI - TBD.  ENCORE SEOUL 2022.  KOREA, REPUBLIC OF
  • (2022)  Cutting Edge Care of Pitavastatin with Ezetimibe Combination Therapy.  대한심장학회 제66차 추계학술대회.  KOREA, REPUBLIC OF
  • (2022)  Ischemic heart failure: Revascularization vs Advanced Heart Failure Therapies.  대한심장학회 제66차 추계학술대회.  KOREA, REPUBLIC OF
  • (2022)  How can I perform T and TAP to achieve Optiaml Restuls.  20th GICS.  KOREA, REPUBLIC OF
  • (2022)  Antiplatelet Therapy and Primary Prevnetion of ASCVD: Aspirin ? Clopidogrel ?.  20th GICS.  KOREA, REPUBLIC OF
  • (2022)  SGLT2 inhibitor can save the life after AMI.  20th GICS.  KOREA, REPUBLIC OF
  • (2022)  Complex Left Main Bifurcation PCI: Change of Strategy.  SCAI 2022.  UNITED STATES
  • (2022)  EBC-MAIN and DERINITION II Studies, What is Different ?.  The 18th KSIC 동계심혈관중재학회.  KOREA, REPUBLIC OF
  • (2021)  One-Month DAPT in ACS: STOPDAPT-2 ACS.  제 17회 심근경색연구회 동계 심포지엄.  KOREA, REPUBLIC OF
  • (2021)  The Next Frontiers? -ARNI, SGLT2 Inhibitors for AMI.  제65차 추계학술대회 KSC.  KOREA, REPUBLIC OF
  • (2021)  Optimal antiplatelet strategy in patients undergoing complex PCI.  ENCORE SEOUL 2021.  KOREA, REPUBLIC OF
  • (2021)  CABG or PCI: which is better for revascularization of coronary artery disease in chronic kidney disease?.  ENCORE SEOUL 2021.  KOREA, REPUBLIC OF
  • (2021)  Essentials of Primary Care - 심근경색치료의 최신 가이드라인.  대한내과학회 춘계학술대회.  KOREA, REPUBLIC OF
  • (2020)  DES II Stent Failure and Complications.  2020앙코르서울.  KOREA, REPUBLIC OF
  • (2020)  Training Center (Sponsored by Medtronic) Key techniques for treating bifurcation lesions 1.  2020앙코르서울.  KOREA, REPUBLIC OF
  • (2020)  Case-based sessions with Video Demo Bifurcation.  2020앙코르서울.  KOREA, REPUBLIC OF